Trials / Completed
CompletedNCT01910064
A Long Term Study of GK530G in Subjects With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 436 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This open label study is to determine the safety profile of GK530G in a long-term treatment (up to 12 months) in subjects with acne vulgaris and to evaluate the efficacy of GK530G in a long-term treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GK530G |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2013-07-29
- Last updated
- 2017-03-28
- Results posted
- 2017-01-05
Locations
16 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01910064. Inclusion in this directory is not an endorsement.